Invest in your #HEOR Team! Take advantage of the value and flexibility our Organization Membership packages offer. Membership provides your team with access to leading journals, online educational offerings, event registration discounts, volunteerism in member groups, and networking in online communities. To learn more, visit the link and complete the request form. 🔗 https://ow.ly/tiBl50XilM4 #MembershipMonday #OrganizationMembership
ISPOR—The Professional Society for Health Economics and Outcomes Research
Hospitals and Health Care
Lawrenceville, NJ 43,084 followers
Improving healthcare decisions
About us
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
- Website
-
http://www.ispor.org
External link for ISPOR—The Professional Society for Health Economics and Outcomes Research
- Industry
- Hospitals and Health Care
- Company size
- 11-50 employees
- Headquarters
- Lawrenceville, NJ
- Type
- Nonprofit
- Founded
- 1995
- Specialties
- HEOR, Health Economics, Outcomes Research, and Health Economics and Outcomes Research
Locations
-
Primary
Get directions
505 Lawrence Square Blvd South
Lawrenceville, NJ 08648, US
Employees at ISPOR—The Professional Society for Health Economics and Outcomes Research
-
Jessica Santos, PhD
Compliance specialist in complex healthcare regulatory, AI governance, privacy and ethics landscape. KOL, Quality by Design, Pragmatic Leader…
-
Mikkel Z. Oestergaard
Executive Director at MSD | Co-Chair of Global Differential Pricing initiative at ISPOR | Strategic Advisor on Access to Medicines at the Max…
-
Amy O'Sullivan
-
Betsy Lane
Chief Marketing & Communications Officer at ISPOR
Updates
-
The ISPOR – SMDM Model Validation II Task Force has recently been established to update the 2012 Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. This task force will solely focus on good practice guidance on model validation for health economic modelers and users, including HTA assessors, HEOR experts and evidence review bodies. We invite all interested ISPOR members to join the review group. Contributors who provide substantive comments on draft reports will be listed by name in the final documents. To join the task force review group, click here: https://ow.ly/WxcO50XhCGO #ModelValidation #EconomicModels #ValidationRequirements #HEOR
-
-
#Interview - In this Clinical Leader article, ISPOR Chief Science Officer Laura Pizzi highlights how ISPOR is shaping health economics and outcomes research (#HEOR) and how improvements in data quality, trial design, and regulatory acceptance are driving real-world evidence (RWE) into the mainstream of drug development. Read the full article: “RWE Is Growing Up, And Here's Why That Matters” https://lnkd.in/edkQR5QB #clinicalleader #RWE #healthcare
-
Session proposal and HEOR Impact Case Study abstract submission is open for ISPOR 2026! Showcase your thought leadership and shape the conversation at the world’s leading conference for health economics and outcomes research (HEOR). The deadline for Session proposals and HEOR Impact Case Studies submissions is December 12. Research abstract submission will open on October 31. Get details here >> https://ow.ly/gQKl50Xemxy #ISPORAnnual #HEOR #HealthEconomics #OutcomesResearch #CallForAbstracts
-
-
We are excited to welcome Dave Snowden, internationally recognized thinker, researcher, and founder of the Cynefin ® -Framework ©, as a keynote speaker at ISPOR Europe 2025! During this keynote, conference attendees will be offered a thought-provoking look at how complexity-based approaches can advance patient-centric decision making and reshape the future of health economics and outcomes research (HEOR). Learn more about the Keynote Address here: https://ow.ly/sZCW50XfWPi Explore the full conference program here: https://ow.ly/vcgE50XfWPh #ISPOREurope #HEOR #Healthcare #ComplexityScience
-
-
Connect with HEOR experts, peers, and healthcare stakeholders from around the world at ISPOR Europe 2025 (9-12 November 2025 in Glasgow, Scotland)! From classic networking opportunities to social experiences infused with learning, the program blends professional growth with meaningful engagement. Don’t miss out! >> Networking Opportunities: https://lnkd.in/eQ5y9p_y Full Program: https://lnkd.in/ec7QU-SV Check out highlights from last year's annual European conference below! #ISPOREurope #HEOR #healthcare
-
#Interview -Listen to this episode of the Business of Biotech podcast featuring Rob Abbott, CEO of ISPOR. He explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. Listen to the full episode here: https://lnkd.in/eSpNNYiX #HEOR #ISPOR #healthcare Life Science Leader
On this week's episode of the Business of Biotech, ISPOR—The Professional Society for Health Economics and Outcomes Research CEO Rob Abbott talks about how HEOR can help early and mid-stage biotechs attract investment dollars by helping to differentiate drug development candidates. Cost-of-illness studies, burden-of-disease analyses, and payer landscape assessments are a few of the tools that can build a case for a drug's market value; Rob explains how companies can set up an HEOR function, as well as how AI, real world evidence, and patient-centered research are being used to improve trial design and accelerates market access. To watch the full episode, click the link in the comments 👇
-
#ISPORNews ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field. Learn more: https://ow.ly/4jZy50XbgmS
-
-
HEOR Headlines in the News: - “RWE Is Growing Up, And Here's Why That Matters” (Clinical Leader) - “Can AI Help Deliver CMS’s Value-Based Care Agenda?" (Health Affairs Forefront) - “The Effect of Disease-Modifying Therapies on Brain Volume Loss and Disability Accumulation in Multiple Sclerosis” (The Lancet Regional Health Europe) Read these and more >> Visit the HEOR News Desk for curated news stories from a variety of sources: https://ow.ly/XVxR50XejWx #HEOR #healthcare #globalhealth
-